Boston Scientific Corp (WBO:BSXC)
€ 68.5 1 (1.48%) Market Cap: 100.27 Bil Enterprise Value: 108.32 Bil PE Ratio: 61.71 PB Ratio: 5.42 GF Score: 73/100

Boston Scientific Corporation Presents at Digestive Disease Week (DDW) 2019, May-20-2019 07:30 AM Transcript

May 20, 2019 / 02:30PM GMT
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

I'm very pleased to have with me this morning, Art Butcher, who is our Senior Vice President and President of Endoscopy; as well as I think someone new to many of the investors in the room, Dr. Brian Durkin (sic) [Dunkin], who is our Vice President of Medical Affairs for Endoscopy, and really pleased to have both of them with us here today.

Next slide, please. Before we begin, the usual safe harbors and disclaimers apply, and we speak you to -- we ask you to consult our risk factors, as stated in our most recent 10-K and 10-Q filings.

And with that, next slide, please, I will hand it over to Art.

Arthur C. Butcher
Boston Scientific Corporation - Senior VP & President of Endoscopy

Susie, thank you very much, and welcome, everybody. We appreciate you taking time to attend DDW and to join us for this investor forum on our endoscopy business. As Susie mentioned, I'm very pleased to have with me this morning our Vice President of Medical Affairs, Dr. Brian Dunkin, who recently

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot